Company Active LTD

Company profile

Image Analysis Limited

IAG | Strategic Imaging for Accelerated Drug Development

Image Analysis Limited is a UK company with status active founded in 2007 based in London.

CRN
06286687
Founded
2007
Age
19

Overview

Legal name
IMAGE ANALYSIS LIMITED
Region
London
Registered address
125 WOOD STREET
LONDON
UNITED KINGDOM
EC2V 7AW
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
33

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

02 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

18 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

20 Jun
2007

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2011
Funded years
2011, 2017, 2018
Age at first award
4 years

Projects

2018 EU-Funded Lead participant

NEWOCT

1 Jul 2018 to 30 Jun 2020

Awarded
£318,696
Total cost £531,160

Awaiting Public Project Summary

2017 Collaborative R&D Lead participant

Improving Brain Tumor Patient Outcomes through Patient Stratification & Novel Biomarkers

1 Oct 2017 to 31 Jul 2019

Awarded
£217,175
Total cost £310,250

Glial tumours are the most common primary brain tumour, and since the majority of these are high-grade (malignant) tumours, overall patient survival is poor. A newly diagnosed glioma may be a slow-growing low-grade™ or a more heterogeneous, highly infiltrative high-grade™. Accurate diagnosis of the tumour grade, and delineation of the tumour core and infi...

2011 GRD Development of Prototype Lead participant

Enterprise Dynamika

1 Dec 2011 to 31 Dec 2013

Awarded
£250,000
Total cost £728,558

MRI is a major tool in clinical routine since it enables early diagnosis and reliable assessment of treatment, especially in arthritis and oncology studies, where timely diagnosis can make a difference between a disability or even death and a recovery to a relatively normal lifestyle. However, the cost of MRI procedures limits its use, which impacts on pa...

Product types

Collaborative R&D EU-Funded GRD Development of Prototype